Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.

Area of Science:

• Virology
• Immunology
• Hepatology

Background:

• Hepatitis C virus (HCV) chronic infection establishment involves interactions with human lipoproteins.
• Apolipoprotein E (ApoE) on the HCV envelope is crucial for viral attachment and immune evasion, primarily within hepatocytes.
• Understanding host-virus interactions is vital for developing prophylactic strategies against HCV, a major cause of liver disease.

Purpose of the Study:

• To investigate the role of secreted apolipoprotein E (sApoE) in extracellular interactions with hepatitis C virus (HCV).
• To determine how sApoE binding to HCV virions affects viral infectivity and pathogenesis.
• To explore the potential implications of these interactions for HCV vaccine development.

Main Methods:

• Analysis of sApoE binding to HCV virions post-release using its C-terminal domain.
• Investigation of the impact of sApoE N-terminus interactions with cell surface receptors on HCV infectivity.
• Assessment of the dependence of extracellular sApoE-HCV binding on HCV envelope proteins.

Main Results:

• Secreted ApoE (sApoE) binds to HCV virions via its C-terminal domain after viral release.
• The binding affinity between the sApoE N terminus and cell receptors influences HCV infectivity in a dose-dependent manner.
• Extracellular binding of sApoE to HCV is mediated by HCV envelope proteins, which can also bind to sApoE.

Conclusions:

• Extracellular interactions between HCV and sApoE represent a significant factor in viral pathogenesis.
• Differential effects of sApoE variants on HCV infection efficiency provide insights into host immunity.
• These findings suggest novel avenues for developing strategies to prevent HCV infection and aid vaccine development.